Mednet Logo
HomeNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

What is your treatment approach for MAG antibody associated polyneuropathy?

2
1 Answers

Mednet Member
Mednet Member
Neurology · Brown University

When patients have a classic Distal acquired demyelinating sensory (DADS) Neuropathy phenotype (by clinical +/- EDX criteria), typically an SPEP/IFE is checked first, and if an IgM monoclonal gammopathy is observed, then I typically check MAG antibodies at that point (if clinical and EDX features ar...

Do you often encounter compressive neuropathies such as carpal tunnel syndrome in patients with spastic cerebral palsy?

1 Answers

Mednet Member
Mednet Member
Neurology · Virtua Health

The issue of movement disorders and spasticity, in particular, is very problematic in people with cerebral palsy. I think, unfortunately, what often happens as these patients grow into adults, is that conditions like compressive neuropathies are simply not thought about. As people with cerebral pals...

How do you counsel patients on the cognitive effects of DBS for Parkinson's disease?

2 Answers

Mednet Member
Mednet Member
Neurology · VUMC Neurology

Cognitive effects after DBS procedures are multifactorial. Many times, patients are affected by Parkinsonian motor manifestations, such as dyskinesia or tremor, and treating these problems successfully with DBS and subsequent medication adjustments can help substantially with cognitive performance. ...

How do you manage levodopa in a patient with Parkinson's and RLS with augmentation?

1
1 Answers

Mednet Member
Mednet Member
Neurology · Emory Clinic

Levodopa is known to cause augmentation or worsening of restless leg syndrome (RLS) symptoms (Högl et al., PMID 19756826). There are varying reports of RLS correlation with Parkinson disease (PD) with most studies noting an association (Ondo et al., PMID 11890847; Peralta et al., PMID 19691124; Calz...

What is your approach to evaluating Tardive Dyskinesia in nonverbal patients?

4
1 Answers

Mednet Member
Mednet Member
Neurology · VUMC Neurology

Nonverbal patients can still be affected by TD, so if there is a significant functional impact, treatment can still be offered. If a patient is completely unable to communicate, it is difficult to assess for side effects or symptomatic improvement, so the risk-to-benefit analysis would be largely un...

How do you counsel patients with blepharospasm regarding driving?

1 Answers

Mednet Member
Mednet Member
Neurology · VUMC Neurology

I do not have a specific protocol for driving with blepharospasm, so I would advise assessing each case individually. Occupational therapy can perform standardized driving assessments for safety if there is a concern.

How do you counsel glioblastoma multiforme patients on which types of clinical trials to pursue?

1 Answers

Mednet Member
Mednet Member
Neurology · MD Anderson Cancer Center

This is a great question! In general, I think that a clinical trial gives someone access to promising therapies (and of course glioblastoma is an aggressive tumor for which we have no cure), but enrolling in one may not feel like the right decision for all patients (for a variety of reasons). I thin...

What is your approach to seronegative presumed pediatric autoimmune encephalitis?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Valley Children's Hospital

My approach is to prove that the patient has that condition through objective testing (labs, imaging, tissue sampling) instead of having a "presumed" diagnosis as I do not treat patients based on presumptions...

How do you treat rotational vertebral artery syndrome?

2
1 Answers

Mednet Member
Mednet Member
Neurology · University of Virginia, School of Medicine

I usually take a multidisciplinary approach to treating these patients. I start the patient on an antithrombotic [at least antiplatelet and if any thrombus due to stasis (or significantly slow flow in those who have had a stroke due to thromboembolism from the area of stasis specifically) then antic...

In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?

4
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Icahn School of Medicine at Mount Sinai

Please forgive me for the length and directness of my response, but I believe it is important to first go over the INDIGO trial and explain why, in my opinion, it was a highly questionable study, with multiple significant methodological flaws and dubious evidence of Vorasidenib's efficacy.INDIGO tri...